ArticleLancet (London, England)2013

Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER).

Eun-Ae Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.